QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 0.05348
-- x --
-- x --
-- - --
$ 0.04 - $ 0.09
1,032,920
na
na
$ 0.72
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

MediPharm Labs (OTC:MEDIF) reported quarterly losses of $(0.01) per share. This is a 40 percent increase over losses of $(0.01)...

Core News & Articles

MediPharm Labs (OTC:MEDIF) reported $8.531 million in sales this quarter. This is a 12.77 percent increase over sales of $7.565...

 this-week-in-cannabis-americas-crackdown-down-on-hemp-global-reform-industry-gathering-in-chicago

Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's...

Core News & Articles

MediPharm Labs (OTC:MEDIF) reported quarterly sales of $7.53 million which missed the analyst consensus estimate of $10.54 mill...

 this-week-in-cannabis-trump-policy-updates-corporate-moves-regulatory-shifts-and-product-innovations

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry trans...

Core News & Articles

MediPharm Labs (OTC:MEDIF) will report on Q4 2024.

 cbd-pharma-co-medipharm-37-increase-in-q3-international-sales-15-yoy-revenue-growth

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third qua...

 medipharm-q2-loss-narrows-adjusted-ebitda-climbs-as-gross-profit-improves-nearly-300-yoy

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday f...

 executive-changes-in-cannabis-industry-you-should-know-about-new-appointments--more

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, w...

 cannabinoids-focused-medipharm-boasts-this-advanced-medical-cannabis-delivery-method

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that...

 this-cannabinoids-focused-pharma-co-sees-50-yoy-surge-in-revenue-in-2023-trims-losses

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday i...

 canadian-cbd-focused-pharma-co-gets-green-light-to-produce-medical-marijuana-in-brazil

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for...

 key-leadership-changes-in-cannabis-you-should-know-about-as-we-head-into-2024

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing tog...

 medipharm-labs-still-hits-c85m-despite-sequential-drop-more-on-that-in-q3-2023-financial-report

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September ...

 new-cannabis-products-energize-global-health--wellness-market-including-australia

In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness ...

 medipharm-settles-commercial-agreement-dispute-with-tilrays-hexo-for-9m

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve...

 new-cbd--thc-cannabis-oils-now-shipping-to-australia-from-canada

MediPharm Labs Corp.

Core News & Articles

GAINERS: EVIO (OTC:EVIO) shares closed up 9900.00% at $0.0001

Core News & Articles

GAINERS: Hemp (OTC:HEMP) shares closed up 100.00% at $0.0002

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION